UCLA Campus    |   UCLA Health    |   School of Medicine Translate:
UCLA Health It Begins With U

Robotic Surgery to remove Prostate Cancer

Print
Email
What Is UCLA Health?

This video is also available in Windows Media at http://streaming.uclahealth.org/prostate-cancer
Barry Broughton
Barry Broughton
Prostate Cancer Survivor

Dr. Robert Reiter
Robert Reiter, M.D.
Director, UCLA Prostate Cancer Treatment and Research Center
 
 
 

Barry’s Story

Barry Broughton is a successful marketing executive who has traveled the world and faced a lifetime of challenges. But few challenges would be as difficult as the diagnosis he received last year of prostate cancer. Barry’s cancer was diagnosed following a test called a PSA, or prostate-specific antigen test, which measures a protein produced by the prostate that is elevated in most men with prostate cancer. A rising PSA indicates the likelihood of a growing cancer, and the faster it rises, the more aggressive the cancer is likely to be.

He was horrified when he heard the news. “Both of my parents died of cancer, and my sister has had her breasts removed … so cancer is prevalent in my family, and it was a very traumatic thing to be told,” he recalls.

Prostate cancer is one of the most-common cancers affecting men. Each year,  220,000 new cases are diagnosed and 29,000 men die from the disease. But that number is down from 40,000 deaths 10 years ago, potentially because of the kind of screening that Barry received.

Barry and his physician, UCLA urologist Dr. Robert Reiter, who is the director of the Prostate Cancer Treatment Program at UCLA, talked about his options for treatment, including radiation and different types of surgery. After much discussion, both Barry and Dr. Reiter felt that surgery, using the latest in robotic technology, to remove his cancerous prostate would be Barry’s best choice.

The technique is minimally invasive, meaning it is performed through small holes in the abdomen through which a camera and instruments are inserted. The instruments have wrist-like joints and can move in all directions, giving the surgeon maximum flexibility and accuracy of movement. In addition, the camera provides three-dimensional images, offering the surgeon an improved visual field as he works the instruments.

And because a long incision is not necessary, there is much less blood loss and patients generally experience less pain and faster recovery, often returning home the next day and back to most activities within a few weeks. The efficacy of the surgery is further enhanced at UCLA by the integration of magnetic resonance imaging, which reduces the risks of leaving cancer behind and improves the chances of sexual recovery.

After his surgery, Barry was up and walking the next day. He quickly regained urinary and sexual function, and, most important to him and his family, Barry is now cancer free.

“They’ve got the old guy still around for a while, and we’re looking for grandchildren one of these days, so we want to be around to be able to enjoy them,” Barry says. “That’s the deal.”

Learn More

To learn more about the UCLA Prostate Cancer Program, visit www.urology.ucla.edu

To learn more about Dr. Reiter, visit www.uclahealth.org/RobertReiter  

Visit our Health Encyclopedia for more information on Prostate Cancer and PSA (prostate-specific antigen).

Visit UCLA Radiology to learn about Prostate MR Imaging

Read more about how UCLA is transforming patient care through Innovation & Technology

Related Links

Prostate Cancer: to Test or Not to Test?

Prostate - Specific Antigen (PSA) Questions & Answers with Dr. Robert Reiter

Prostate - Specific Antigen (PSA) Questions & Answers with Dr. Mark Litwin

Screening Markers, Imaging Allies in Fight Against Prostate Cancer

Prostate cancer patients sought for clinical trials

Newer imaging techniques superior in detecting and localizing prostate cancer

 

Click here for more patient stories

Visit us on FACEBOOK to share your story.

stay connected   Twitter Facebook You Tube RSS Mobile